SPTAN1 Expression Predicts Treatment and Survival Outcomes in Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality. In a cohort of 189 patients with CRC, we recently showed that expression of the cytoskeletal scaffolding protein non-erythroid spectrin αII (SPTAN1) was lower in advanced metastatic tumours. The aim of the present...
Main Authors: | Christopher Schrecker, Sophia Behrens, Rebecca Schönherr, Anne Ackermann, Daniel Pauli, Guido Plotz, Stefan Zeuzem, Angela Brieger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/14/3638 |
Similar Items
-
A Child with a c.6923_6928dup (p.Arg2308_Met2309dup) SPTAN1 Mutation Associated with a Severe Early Infantile Epileptic Encephalopathy
by: Valentina Rapaccini, et al.
Published: (2018-07-01) -
Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.
by: Anne Ackermann, et al.
Published: (2019-01-01) -
Defects in Cytoskeletal Signaling Pathways, Arrhythmia, and Sudden Cardiac Death
by: Sakima A Smith, et al.
Published: (2012-05-01) -
The axonal actin-spectrin lattice acts as a tension buffering shock absorber
by: Sushil Dubey, et al.
Published: (2020-04-01) -
Reciprocal interactions between cell adhesion molecules of the immunoglobulin superfamily and the cytoskeleton in neurons
by: Vladimir eSytnyk, et al.
Published: (2016-02-01)